Vaccine Safety Body Proposed To Remove FDA “Conflict Of Interest”
Executive Summary
A proposal to move postmarket vaccine safety monitoring to an independent board outside FDA and CDC will be considered by the National Vaccine Advisory Committee at its next meeting
You may also be interested in...
IoM finds no thimerosal link to autism
Neither the measles-mumps-rubella vaccine nor thimerosal-containing vaccines are associated with autism, a May 17 Institute of Medicine report says. The 1report, "Immunization Safety Review: Vaccines and Autism," updates a 2001 report that found the link between thimerosal and neurodevelopmental disorders was unclear (2"The Pink Sheet" Oct. 8, 2001, p. 11). The latest report is based on "overwhelming evidence from several well-designed" clinical and epidemiological studies...
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials